Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

Pacira BioSciences Inc

PCRX
23,10
-0,27 (-1,16%)
11 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/3/202510:45PRNUSShareholders that lost money on Pacira BioSciences,..
06/3/202518:06EDGAR2Form 144 - Report of proposed sale of securities
06/3/202514:00GLOBEPacira BioSciences Reports Inducement Grants Under Nasdaq..
06/3/202511:45PRNUSThe Gross Law Firm Notifies Shareholders of Pacira..
03/3/202511:45PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
27/2/202523:07EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/2/202522:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202522:06EDGAR2Form 8-K - Current report
27/2/202522:05GLOBEPacira BioSciences Reports Fourth Quarter and Full-Year 2024..
27/2/202522:00GLOBEPacira BioSciences Acquires Remaining Equity Stake of GQ Bio
27/2/202511:45PRNUSShareholders that lost money on Pacira BioSciences,..
26/2/202514:00GLOBEPacira BioSciences to Participate in Fireside Chat at Two..
24/2/202511:45PRNUSPacira BioSciences, Inc. Class Action: The Gross Law Firm..
20/2/202514:00GLOBEPacira to Report 2024 Financial Results on Thursday February..
20/2/202511:45PRNUSInvestors in Pacira BioSciences, Inc. Should Contact The..
13/2/202511:45PRNUSThe Gross Law Firm Reminds Pacira BioSciences, Inc...
10/2/202511:45PRNUSPacira BioSciences, Inc. Securities Fraud Class Action..
06/2/202514:00GLOBEPacira BioSciences Reports Inducement Grants Under Nasdaq..
06/2/202511:45PRNUSThe Gross Law Firm Notifies Shareholders of Pacira..
05/2/202500:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202500:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202500:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202500:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202511:45PRNUSThe Gross Law Firm Announces the Filing of a Securities..
30/1/202514:01EDGAR2Form 8-K - Current report
30/1/202514:00GLOBEPacira Announces Updates to Board of Directors
30/1/202511:45PRNUSThe Gross Law Firm Notifies Shareholders of Pacira..
28/1/202523:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
27/1/202511:45PRNUSInvestors in Pacira BioSciences, Inc. Should Contact The..
23/1/202511:45PRNUSInvestors who lost money on Pacira BioSciences, Inc.(PCRX)..
21/1/202514:05EDGAR2Form 8-K - Current report
21/1/202514:00GLOBEPacira BioSciences Strengthens Executive Leadership Team..
20/1/202511:45PRNUSPacira BioSciences, Inc. Sued for Securities Law Violations..
16/1/202511:45PRNUSPacira BioSciences, Inc. Sued for Securities Law Violations..
10/1/202514:01EDGAR2Form 8-K - Current report
10/1/202514:00GLOBEPacira Announces New Five-Year Objectives to Accelerate..
07/1/202514:00GLOBEPacira BioSciences Receives FDA 510k Clearance for New..
07/1/202500:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202500:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202500:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202500:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202517:11EDGAR2Form 144 - Report of proposed sale of securities
02/1/202522:01GLOBEPacira BioSciences to Present at the 43rd Annual J.P. Morgan..
16/12/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202415:41EDGAR2Form 144 - Report of proposed sale of securities
11/12/202414:05PRNUSDOMA Perpetual Capital Management Announces Intent to..
06/12/202414:00GLOBEPacira BioSciences Reports Inducement Grants Under Nasdaq..
03/12/202413:30GLOBEPacira Awarded New U.S. Patent Covering EXPAREL Composition
14/11/202416:05GLOBEPacira Announces 104-Week Safety and Efficacy Data Following..
12/11/202414:00GLOBEPacira BioSciences to Participate in Fireside Chat at Two..
Apertura: 22,75 Min: 22,62 Max: 23,47
Chiusura: 23,37

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network